Therefore, in the medical care for colorectal cancer, if the dMMR testing result shows MSI-H or the loss of MLH1/PMS2 expression, checking for the BRAF V600E mutation helps distinguish Lynch syndrome-related colorectal cancers from sporadic ones [62]. This evidence concerns the gene BRAF and Lynch syndrome.